Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2007-04-03
2007-04-03
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
C514S079000, C514S110000
Reexamination Certificate
active
10129352
ABSTRACT:
The invention relates to the use of treosulfan as a conditioning agent before allogenic transplantation of bone marrow or haematopoietic stem cells, whereby treosulfan is administered, either as single effective agent, or in combination with other chemotherapetic agents or immunosuppressant agents.
REFERENCES:
Carter, Stephan K., M.D. et al.; Chemotherapy of Cancer, Second Edition, (1981); A Wiley & Sons, New York, New York; pp. 362-365.
Ploemacher, et al., Treosulfan as an Alternative Conditioning Agent in Bone Marrow Transplantation, Nov. 15, 1999, Blood, 94, 10 Suppl. 1 pt. 2, p. 324b.
Parkman, et al., Busulfan and Total Body Irradiation as Antihematopoietic Stem Cell Agents in the Preparation of Patients with Congenital Bone Marrow Disorders for Allogenic Bone Marrow Transplantation, 1984, Blood, 64(4), 852-7.
Parfitt, K. Ed. Martindale: The Complete Drug Reference, 32nd edition, 1999, pp. 509-511, 516-517 and 568.
Jabado, et al., Bone Marrow Transplantation from Genetically HLA-Nonidentical Donors in Children with Fatal Inherited Disorders Excluding Severe Combined Immunodeficiencies, 1996, Pediatrics, 98, 420-8.
Hirabayashi, et al., Busulfan, Cyclophosphamide and Total Body Irradiation as Conditioning for Allogenic Bone Marrow Transplantation for Acute and Chronic Myeloid Leukemia, 1998, Bone Marrow Transplant, 21, 1079-83.
Gulati et al., “Comparison of single-, double- or triple-exposure protocols for the rodent bone marrow/ peripheral blood micronucleus assay using 4-aminobiphenyl and treosulphan”Mutation Research234: 135-139 (1990).
Medac Gesellschaft fur Klinische Spezialpraparate mbH
Needle & Rosenberg PC
Wang Shengjun
LandOfFree
Use of treosulfan for patient conditioning before bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of treosulfan for patient conditioning before bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of treosulfan for patient conditioning before bone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732951